Medications

Valeant under US federal investigation over drug pricing

Canadian pharmaceutical group Valeant says it has received subpoenas from US federal prosecutors seeking information about the pricing and distribution of its drugs, along with how it makes them more affordable for patients.

Medications

FTC sending refunds over CVS business overcharging

(AP)—The Federal Trade Commission says it is mailing refund checks to 13,000 Medicare beneficiaries who were overcharged for drugs because a CVS Caremark Corp. business understated the price of the products.

Cardiology

Outcomes-based pricing doesn't cut costs of PCSK9 inhibitors

(HealthDay)—Outcomes-based pricing does not reduce the costs of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, according to a research letter published online April 3 in the Annals of Internal Medicine.

Medications

Toward competitive generic drug prices in Canada

The commitment of Canadian premiers to lower generic drug prices is a major change in how the country prices generic drugs, and government should learn from past attempts, states an article published in CMAJ (Canadian Medical ...

Health

Obama administration sets stage for a debate on drug costs

The Obama administration set the stage Friday for a national debate on the rising cost of prescription drugs, a pressing issue for voters but one that's unlikely to see quick solutions under a lame-duck president facing an ...

page 13 from 22